Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2000The FASEB Journal

Infusion of recombinant human acid sphingomyelinase into Niemann‐Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSílvia R.P. MirandaUniversidade Estadual de Campinas (UNICAMP)XHXingxuan HeIcahn School of Medicine at Mount SinaiCSCalogera M. SimonaroIcahn School of Medicine at Mount Sinai

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miranda et al. (2000) studied this question.

synapsesocial.com/papers/6aa1657e29de6bf265b56cf8https://doi.org/10.1096/fj.00-0014com
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Cellular Trafficking and Zinc Dependence of Secretory and Lysosomal Sphingomyelinase, Two Products of the Acid Sphingomyelinase Gene1998 · 244 citations
  2. 2Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.1979 · 88 citations
  3. 3Induced Degradation of Glycosaminoglycans in Hurler's and Hunter's Syndromes by Plasma Infusion1971 · 159 citations
  4. 4Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease1991 · 1,271 citations